I like to keep up to date with the emerging evidence, so every few months I do a literature search for things I’ve not seen or missed before. Here are two papers from 2017 covering different potential medications for BPS that I found interesting, and not necessarily for what you may initially think.
I love it when clinical trial failure is published, it always teaches us much more than outright success. If only more failure was shared!
Here are the references:
Wang. H, Russell. J, Kelly. K, Wang. S, Thipphawong. J. (2017) Fulranumab in patients with interstitial cystitia/bladder pain syndrome: observations from a randomized, double-blind, placebo controlled study. BMC Urology, 17:2.
Lim. Y, Dwyer. P, Murray. C, Karmakar. D, Rosamilia. A, Thomas. E. (2017) Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 28:1085-1089